The slip
PARKINSON RECEIPTno. 13472
28 Oct 2026, 23:02 UTCmicroglia, braak
predictionMCF2L in microglia tracks Braak Lewy-body stage
registered970f0bee8c4fc6ec
discovery-0.32 p=0.407 n=9
replication-0.11 p=0.787 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.32, p 0.407)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTf300f4d21001626ac70cc647…
follows cb320168de43…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13472: MCF2L in microglia, braak
- power
- full sample -0.15 (p 0.561, n 18), 95% CI -0.57 to +0.34. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.07 (p 0.774, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.02 (p 0.935, n 18). could be the mix.
- skeptic
- leave-one-out range -0.31 to -0.03, sign flips 0; without severely affected donors -0.15 (p 0.561, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MCF2L in microglia.
case closed: nothing better to follow up.